Europe PMC requires Javascript to function effectively.

Either your web browser doesn't support Javascript or it is currently turned off. In the latter case, please turn on Javascript support in your web browser and reload this page.

Search life-sciences literature (45,104,206 articles, preprints and more)

Search results

1-25 of 52 results

Sort by:

Relevance ^{Relevance: This is determined based on a ranking of criteria including term frequency, rarity of term, recency of article, whether there is a Title or Author field match, etc.}

Times cited

Date

1 2 3

The benefits and harms of adjuvant chemotherapy for non-small cell lung cancer in patients with major comorbidities: A simulation study.
Leiter A, Kong CY, Gould MK, Kale MS, Veluswamy RR, Smith CB, Mhango G, Huang BZ, Wisnivesky JP, Sigel K
PLoS One, 17(11):e0263911, 15 Nov 2022
Cited by: 2 articles | PMID: 36378625 | PMCID: PMC9665372
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Overall Survival Prediction of Docetaxel-based Second-line Treatment for Advanced Non-small Cell Lung Cancer: A Systematic Review and Meta-analysis.
Nagaraju C, Vaidya G, Jain AS, Nair AP, Chandrappa S, Srinivasa C, Suresh KP, Patil SS, Shivananda B, Kollur SP, Shivamallu C
Oman Med J, 37(5):e419, 30 Sep 2022
Cited by: 2 articles | PMID: 36341003 | PMCID: PMC9618033
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Treatment Outcome and Safety of the TCX Regimen for Advanced Gastric Cancer: A Prospective Cohort Study.
Nguyen HT, Do KH, Le NB, Tran T
Cancer Manag Res, 14:2825-2837, 19 Sep 2022
Cited by: 1 article | PMID: 36164467 | PMCID: PMC9507975
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Optimizing the use of adjuvant chemotherapy in non-small cell lung cancer patients with comorbidities.
Bailey S, Wang Q, Kong CY, Stone K, Veluswamy R, Bates SE, Smith CB, Wisnivesky JP, Sigel K
Curr Probl Cancer, 46(4):100867, 21 May 2022
Cited by: 0 articles | PMID: 35687964 | PMCID: PMC9276637
Add to export list Free full text in Europe PMC
Efficacy and Toxicity of Different Chemotherapy Protocols for Concurrent Chemoradiation in Non-Small Cell Lung Cancer-A Secondary Analysis of the PET Plan Trial.
Gkika E, Lenz S, Schimek-Jasch T, Waller CF, Kremp S, Schaefer-Schuler A, Mix M, Küsters A, Tosch M, Hehr T, Eschmann SM, Bultel YP, Hass P, Fleckenstein J, Thieme AH, Stockinger M, Dieckmann K, Miederer M, Holl G, [...] Nestle U
Cancers (Basel), 12(11):E3359, 13 Nov 2020
Cited by: 1 article | PMID: 33202825 | PMCID: PMC7697287
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Clinical benefits of adjuvant chemotherapy with carboplatin and gemcitabine in patients with non-small cell lung cancer: a single-center retrospective study.
Takashima S, Imai K, Atari M, Matsuo T, Nakayama K, Sato Y, Motoyama S, Shibata H, Nomura K, Minamiya Y
World J Surg Oncol, 18(1):263, 08 Oct 2020
Cited by: 5 articles | PMID: 33032626 | PMCID: PMC7545843
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
A phase I/II study of weekly nab-paclitaxel plus cisplatin in chemotherapy-naïve patients with advanced non-small-cell lung cancer.
Hattori Y, Kono Y, Itoh S, Inoue T, Urata Y, Kawa Y, Tohnai R, Kumagai T, Nishino K, Uozumi R, Morita S, Negoro S, Imamura F, Satouchi M
BMC Cancer, 20(1):115, 11 Feb 2020
Cited by: 3 articles | PMID: 32046667 | PMCID: PMC7014598
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Cisplatin versus carboplatin in combination with third-generation drugs for advanced non-small cell lung cancer.
Vasconcellos VF, Marta GN, da Silva EM, Gois AF, de Castria TB, Riera R
Cochrane Database Syst Rev, 1:CD009256, 13 Jan 2020
Cited by: 26 articles | PMID: 31930743 | PMCID: PMC6956680
Add to export list Review Free full text in Europe PMC
Association Between Pretreatment Dietary Preference and Weight Loss after Radiation Therapy in Head and Neck Cancer Patients: A Pilot Study.
Vittayakasemsont K, Klaitong C, Phukosi K, Chavasit V, Sinthusek T, Trachootham D
Nutr Cancer, 71(2):230-239, 05 Mar 2019
Cited by: 3 articles | PMID: 30836019
Add to export list
Oridonin enhances the radiosensitivity of lung cancer cells by upregulating Bax and downregulating Bcl-2.
Li S, Shi D, Zhang L, Yang F, Cheng G
Exp Ther Med, 16(6):4859-4864, 27 Sep 2018
Cited by: 15 articles | PMID: 30546402 | PMCID: PMC6256844
Add to export list Free full text in Europe PMC
Should patients with stage IB non-small cell lung cancer receive adjuvant chemotherapy? A comparison of survival between the 8th and 7th editions of the AJCC TNM staging system for stage IB patients.
Wang J, Wu N, Lv C, Yan S, Yang Y
J Cancer Res Clin Oncol, 145(2):463-469, 24 Nov 2018
Cited by: 18 articles | PMID: 30474757
Add to export list
Correlation between different carboplatin dosing patterns and its toxicity analysis in patients with advanced lung cancers: A retrospective study.
Kartolo A, Robinson A
J Oncol Pharm Pract, 25(5):1082-1088, 03 May 2018
Cited by: 0 articles | PMID: 29720041
Add to export list
Pharmacokinetic/pharmacodynamic modeling of combination-chemotherapy for lung cancer.
Curtis LT, van Berkel VH, Frieboes HB
J Theor Biol, 448:38-52, 01 Apr 2018
Cited by: 9 articles | PMID: 29614265 | PMCID: PMC5958901
Add to export list Free full text in Europe PMC
A phase II study of biweekly gemcitabine and carboplatin in completely resected stage IB-IIIA non-small cell lung cancer.
Sakurai R, Tomizawa Y, Yoshii A, Miura Y, Tsurumaki H, Kaira K, Sunaga N, Kawashima O, Hisada T, Yamada M, Saito R
Cancer Chemother Pharmacol, 81(1):103-109, 09 Nov 2017
Cited by: 3 articles | PMID: 29124327
Add to export list
Effectiveness of adjuvant carboplatin-based chemotherapy compared to cisplatin in non-small cell lung cancer.
Couillard-Montminy V, Gagnon PY, Fortin S, Côté J
J Oncol Pharm Pract, 25(1):44-51, 21 Aug 2017
Cited by: 5 articles | PMID: 28825377
Add to export list
Carboplatin versus two doses of cisplatin in combination with gemcitabine in the treatment of advanced non-small-cell lung cancer: Results from a British Thoracic Oncology Group randomised phase III trial.
Ferry D, Billingham L, Jarrett H, Dunlop D, Woll PJ, Nicolson M, Shah R, Thompson J, Spicer J, Muthukumar D, Skailes G, Leonard P, Chetiyawardana AD, Wells P, Lewanski C, Crosse B, Hill M, Gaunt P, O'Byrne K
Eur J Cancer, 83:302-312, 04 Aug 2017
Cited by: 12 articles | PMID: 28780466 | PMCID: PMC5597318
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
First-line treatment of nonsquamous NSCLC using gemcitabine: a retrospective study of real-life practice.
Kohutek F, Stratena M, Rosik A, Tamasova M, Bystricky B
Lung Cancer Manag, 5(3):123-130, 03 Nov 2016
Cited by: 1 article | PMID: 30643556 | PMCID: PMC6310349
Add to export list Free full text in Europe PMC
Utility of day 8 blood tests on platinum plus vinorelbine regimen.
Vázquez-Sánchez R, Diez-Fernández R, Enrech-Frances S, Sánchez-Peña A, Molina-García T
Int J Clin Pharm, 38(4):793-796, 10 May 2016
Cited by: 0 articles | PMID: 27164956
Add to export list
BRAFV600 mutant non-small-cell lung cancer resistant to Vemurafenib.
El Karak F, Assi T, Kourie HR, El Rassy E, Chebib R, Ghor M, Tabchi S
Int J Clin Exp Pathol, 8(3):3294-3298, 01 Mar 2015
Cited by: 2 articles | PMID: 26045855 | PMCID: PMC4440164
Add to export list Free full text in Europe PMC
Nedaplatin- versus cisplatin-based chemotherapy in the survival time of patients with non-small cell lung cancer.
Shan J, Xiong Y, Wang D, Xu M, Yang YI, Gong K, Yang Z, Wang GE, Yang X
Mol Clin Oncol, 3(3):543-549, 06 Feb 2015
Cited by: 5 articles | PMID: 26137264 | PMCID: PMC4471614
Add to export list Free full text in Europe PMC
A systematic review of the clinical effectiveness of first-line chemotherapy for adult patients with locally advanced or metastatic non-small cell lung cancer.
Pilkington G, Boland A, Brown T, Oyee J, Bagust A, Dickson R
Thorax, 70(4):359-367, 06 Feb 2015
Cited by: 66 articles | PMID: 25661113
Add to export list Review
Pharmacokinetic and toxicity considerations in the use of neoadjuvant chemotherapy for bladder cancer.
Narayan V, Vaughn D
Expert Opin Drug Metab Toxicol, 11(5):731-742, 21 Jan 2015
Cited by: 7 articles | PMID: 25604887
Add to export list Review
Phase II trial of carboplatin and pemetrexed as first-line chemotherapy for non-squamous non-small cell lung cancer, and correlation between the efficacy/toxicity and genetic polymorphisms associated with pemetrexed metabolism: Hokkaido Lung Cancer Clinical Study Group Trial (HOT) 0902.
Kanazawa K, Yokouchi H, Wang X, Ishida T, Fujita Y, Fujiuchi S, Harada T, Harada M, Takamura K, Oizumi S, Kinoshita I, Katsuura Y, Honjo O, Kojima T, Dosaka-Akita H, Isobe H, Munakata M, Nishimura M, Hokkaido Lung Cancer Clinical Study Group
Cancer Chemother Pharmacol, 74(6):1149-1157, 08 Oct 2014
Cited by: 8 articles | PMID: 25294632
Add to export list
Prognostic significance of circulating tumor cells in advanced non-small cell lung cancer patients treated with docetaxel and gemcitabine.
Juan O, Vidal J, Gisbert R, Muñoz J, Maciá S, Gómez-Codina J
Clin Transl Oncol, 16(7):637-643, 12 Nov 2013
Cited by: 44 articles | PMID: 24217975
Add to export list
Elderly subset analysis of randomized phase III study comparing pemetrexed plus carboplatin with docetaxel plus carboplatin as first-line treatment for patients with locally advanced or metastatic non-small cell lung cancer.
Pereira JR, Cheng R, Orlando M, Kim JH, Barraclough H
Drugs R D, 13(4):289-296, 01 Dec 2013
Cited by: 9 articles | PMID: 24277116 | PMCID: PMC3851706
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC

1-25 of 52 results

1 2 3

Search life-sciences literature (45,104,206 articles, preprints and more)

Search results

Partnerships & funding